David Heupel
David Heupel
guidance line stock
The 2007 and 2008 guidance is in line with expectations. And the stock is back down after a pretty big move.
chance good
There's a good chance this will come down to the shareholders.
There's nothing too provocative here ? most of it makes sense.
area business concerned nike people share
Nike will be a share gainer in the U.S.. Their U.S. business has been excellent. The area most people are concerned about is Europe.
compete dollars eighty number rationally
Eighty dollars is a 'wow' number ? I don't think there's any way J&J can rationally compete with that.
companies good move seen
We've seen a lot of pharmaceutical companies move out of their non-core businesses. It's a pretty good move.
company deal intact until
They're doing anything and everything to keep the company intact until the (merger) deal is done.
best johnson offer room suspect
I suspect $68 is Johnson & Johnson's best offer ? they don't have much room to go higher.
areas business correctly driven drives entering growth pricing products
What drives this business now is pricing its products correctly and making the right assumptions on costs. They also are entering into areas that will be more growth driven in the future.